(Q38982413)

8 September 2017

1 reference

title

The impact of insulin resistance on the kidney and vasculature (English)

1 reference

8 September 2017

1 reference

5

1 reference

8 September 2017

6

Hans-Ulrich Häring

1 reference

8 September 2017

4

Andreas Fritsche

1 reference

8 September 2017

3

Cora Weigert

1 reference

8 September 2017

2

Erwin Schleicher

1 reference

8 September 2017

1

Ferruh Artunc

1 reference

PubMed ID

27748389

8 September 2017

language of work or name

English

0 references

publication date

17 October 2016

1 reference

Nature Reviews Nephrology

8 September 2017

1 reference

8 September 2017

12

1 reference

8 September 2017

12

1 reference

8 September 2017

721-737

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2016.145

8 September 2017

0 references

cites work

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Impaired insulin action in the human brain: causes and metabolic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Alternative splicing of human insulin receptor messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Atypical protein kinase C in insulin action and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The role of protein phosphatase-1 in insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Lipid phosphatases as drug discovery targets for type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

SOCS-3 is an insulin-induced negative regulator of insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Grb10 and Grb14: enigmatic regulators of insulin action--and more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin-induced serine phosphorylation of IRS-2 via ERK1/2 and mTOR: studies on the function of Ser675 and Ser907.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Phosphorylation of serine 1137/1138 of mouse insulin receptor substrate (IRS) 2 regulates cAMP-dependent binding to 14-3-3 proteins and IRS2 protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Interplay and effects of temporal changes in the phosphorylation state of serine-302, -307, and -318 of insulin receptor substrate-1 on insulin action in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The phosphorylation of Ser318 of insulin receptor substrate 1 is not per se inhibitory in skeletal muscle cells but is necessary to trigger the attenuation of the insulin-stimulated signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin receptor signaling in normal and insulin-resistant states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Hyperactivation of protein phosphatase 2A in models of glucolipotoxicity and diabetes: potential mechanisms and functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Multiple tissue-specific roles for the O-GlcNAc post-translational modification in the induction of and complications arising from type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Vascular actions of insulin with implications for endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The insulin receptor and the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The human glomerular podocyte is a novel target for insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin binding sites in various segments of the rabbit nephron

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Obesity and Risk for Chronic Renal Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Predictors of new-onset kidney disease in a community-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The biological consequence of obesity on the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

A central body fat distribution is related to renal function impairment, even in lean subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Metabolic syndrome and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Influence of smoking and obesity on the development of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Gut metagenome in European women with normal, impaired and diabetic glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The role of hepatokines in metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Identification and characterization of metabolically benign obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The metabolically benign and malignant fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Fetuin-A induces cytokine expression and suppresses adiponectin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Fetuin-A and incident diabetes mellitus in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Plasma fetuin-A levels and the risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Association between higher serum fetuin-A concentrations and abnormal albuminuria in middle-aged and elderly chinese with normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Provocation of postural hypotension by insulin in diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin Enhances Endothelial Function Throughout the Arterial Tree in Healthy But Not Metabolic Syndrome Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Hemodynamic actions of insulin: beyond the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Clathrin-dependent entry and vesicle-mediated exocytosis define insulin transcytosis across microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Nitric oxide directly promotes vascular endothelial insulin transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

An integrated view of insulin resistance and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1/2 to the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Globular adiponectin controls insulin-mediated vasoreactivity in muscle through AMPKα2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Renal and ocular hemodynamic effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Altered renal microvascular response in Zucker obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Perivascular adipose tissue: An unique fat compartment relevant for the cardiometabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Perivascular adipose tissue, potassium channels, and vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Regional differences in perivascular adipose tissue impacting vascular homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Gasotransmitters in Vascular Complications of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Perivascular Fat and the Microcirculation: Relevance to Insulin Resistance, Diabetes, and Cardiovascular Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Luminal and basolateral uptake and degradation of insulin in the proximal tubules of the dog kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin's acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin's acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin is a potent survival factor in mesangial cells: role of the PI3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The Gly(972)Arg variant of human IRS1 gene is associated with variation in glomerular filtration rate likely through impaired insulin receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

In vitro silencing of the insulin receptor attenuates cellular accumulation of fibronectin in renal mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin regulates SOCS2 expression and the mitogenic effect of IGF-1 in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Effects of insulin and high glucose on mobilization of slo1 BKCa channels in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin signaling to the glomerular podocyte is critical for normal kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin stimulates volume absorption in the rabbit proximal convoluted tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The effects of glucose and insulin on renal electrolyte transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Sodium-retaining effect of insulin in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Chronic sodium-retaining action of insulin in diabetic dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin-stimulated trafficking of ENaC in renal cells requires PI 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The physiological impact of the serum and glucocorticoid-inducible kinase SGK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Impaired sodium excretion and increased blood pressure in mice with targeted deletion of renal epithelial insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Salt sensitivity of nitric oxide generation and blood pressure in mice with targeted knockout of the insulin receptor from the renal tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Reduced ENaC activity and blood pressure in mice with genetic knockout of the insulin receptor in the renal collecting duct

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Regulation of ENaC in mice lacking renal insulin receptors in the collecting duct

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Important role of the kidney in human carbohydrate metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Deletion of the insulin receptor in the proximal tubule promotes hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Intrinsic gluconeogenesis is enhanced in renal proximal tubules of Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Regulation of the human Na+-dependent glucose cotransporter hSGLT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin receptor knock-out mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Effect of insulin on renal sodium handling in hyperinsulinaemic type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Stimulatory effect of insulin on renal proximal tubule sodium transport is preserved in type 2 diabetes with nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Preserved Na/HCO3 cotransporter sensitivity to insulin may promote hypertension in metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

mTORC2 critically regulates renal potassium handling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Lifestyle intervention in individuals with normal versus impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Impact of a lifestyle program on vascular insulin resistance in metabolic syndrome subjects: the RESOLVE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

7. Approaches to Glycemic Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Actions of peroxisome proliferator-activated receptors-gamma agonists explaining a possible blood pressure-lowering effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Glucolipotoxicity: fuel excess and beta-cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin resistance in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Basal insulin and cardiovascular and other outcomes in dysglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Association of AHSG Gene Polymorphisms With Fetuin-A Plasma Levels and Cardiovascular Diseases in the EPIC-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin binding, biologic activity, and metabolism of biosynthetic human insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Distinct alpha-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Binding of insulin-like growth factor-I by glomerular endothelial and epithelial cells: further evidence for IGF-I action in the renal glomerulus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Immunohistochemical localization of collagen VI in diabetic glomeruli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Characterization of the receptors for insulin and the insulin-like growth factors on micro- and macrovascular tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Receptor-mediated transport of insulin across endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Arg⁹⁷² insulin receptor substrate-1 inhibits endothelial nitric oxide synthase expression in human endothelial cells by upregulating microRNA-155.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin receptor substrate-2 (Irs2) in endothelial cells plays a crucial role in insulin secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Effects of insulin on rat renal microvessels: studies in the isolated perfused hydronephrotic kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Intra-renal hemodynamics and carotid intima-media thickness in the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Exercise-induced albuminuria is associated with perivascular renal sinus fat in individuals at increased risk of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin increases the activity of mesangial BK channels through MAPK signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Nephrin Is Critical for the Action of Insulin on Human Glomerular Podocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Tubular effects of insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Control by insulin of sodium potassium and water excretion by the isolated dog kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Early neonatal death in mice homozygous for a null allele of the insulin receptor gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Insulin and renal sodium retention in obese adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Physical training improves flow-mediated dilation in patients with the polymetabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

High Visceral Fat Mass and High Liver Fat Are Associated with Resistance to Lifestyle Intervention*

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.145

Hemodynamic actions of insulin

31 March 2020

1 reference

12 December 2020

Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality

1 reference

12 December 2020

Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance

1 reference

12 December 2020

Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation

1 reference

12 December 2020

Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys

1 reference

12 December 2020

Sustained hyperinsulinemia increases arterial pressure in conscious rats

1 reference

12 December 2020

Adiponectin regulates albuminuria and podocyte function in mice

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2016.145

1 reference

8 September 2017

1 reference

PubMed ID

27748389